When scientists find a cure for cancer. When will a universal cure for cancer be invented?

After all, you can make an injection of immunocytes that kill all foreign cells and leave the patient in a sterile room.

In addition, there are already quite a few drugs and methods for treating cancer in the early stages and fairly reliable methods for early diagnosis of cancer, when these drugs can still be used.

The fact is that cancer cells arise as a result of the evolution of ordinary cells of the body. The cells of the body are also living beings, and there is also a competition between them for the limited resources that come to them.

Cells try to evolve in such a way as to win this fight, and as a result, cancer cells arise, which really begin to win very effectively in local competition for a resource. But at the same time, they suppress other useful cells and the whole organism as a whole begins to die.

Removing these cells does not help, because the conditions for their appearance have not disappeared and they appear again as a result of the evolution of the remaining normal cells. It is impossible to destroy them completely in the body, just as it is impossible to exterminate rats on Earth.

Finding a cure for cancer is not an easy task. There is an opinion that this is the natural evolutionary path of all cells of the human body in general, and that supposedly no other evolutionary path of cells is possible.

It is possible to stop cancer at an early stage, but at the terminal (3B-4 degree) only surgical surgical treatment and faith in the Almighty remain ...

How to fight if you are not a doctor?

Unfortunately, many people die from cancer of various types. And this happens in most cases for the reason that the diagnosis is not established in a timely manner. How to avoid this and what to do to reduce the risk of getting this disease was told by the executive director of the Cancer Prevention Foundation, oncologist Ilya Fomintsev.

Ilya, tell me, please, what types of oncology are most common now?

In Russia, these are breast cancer, lung cancer, colorectal cancer (colon and rectum), stomach cancer, skin cancer, prostate cancer and cervical cancer.

Is it true that at the initial stage, any type of cancer can be treated? What kind of cancer is the easiest to get rid of?

All of the above cancers are really excellent for treatment at an early stage. Only now people understand different things by the early stage. Sometimes oncologists are cunning, calling the first and second stages early. In fact, only the first stage is really early.

But some cancers, even at an early stage, are very dangerous: for example, pancreatic cancer. Even at small volumes, it can critically disrupt human anatomy. The same can be said about high-grade brain tumors. Much depends on the biology of the tumor.

How much, at least, can cancer treatment take?

If the stage is early and radiation therapy and chemotherapy are not required, then the treatment can actually take a week. So much, for example, is needed for hospitalization for radical resection for breast cancer.

What examinations and how often should be carried out in order to monitor your health and, in which case, to detect cancer at an early stage?

Surveys for each age and sex group are different. Much depends on the risk factors and heredity that a person has. In order to more or less individually and at the same time massively answer this question, the Cancer Prevention Foundation created a special online test.

By answering a few simple questions in a couple of minutes, you can get individual recommendations for those examinations that you need. In fact, this is a cancer risk test, as a result of which we give individual recommendations for regular examinations, based on world experience. The test can be taken on the Foundation's website - www.nenaprasno.ru

Ilya, can cancer be treated without surgery?

Yes, in some cases, you can do with only radiation therapy or only chemotherapy. For example, skin basaliomas are treated in this way. Even prostate cancer in certain clinical situations is perfectly treated without surgery.

Is chemotherapy always done?

No, chemotherapy is given when it is indicated. If we talk about the radical treatment of cancer, now these indications are quite wide and chemotherapy is carried out, I think, already in 60-70% of cases with radical cancer treatment. Much depends on the stage and immunohistochemical type of the tumor.

Have there been any recent innovative methods of oncology treatment that are used in our country?

Innovative therapies are now generally referred to as high-tech improvements to traditional therapies. Still, there are no fundamentally new methods of cancer treatment: it is still surgery, chemotherapy and radiation therapy.

For example, in oncosurgery, endovideo technology is gaining momentum, in chemotherapy - treatment with monoclonal antibodies, and in radiation - high-precision methods of positioning using computers. One problem - it's very, very expensive things.

They say that if the cancer has already been, it can return. Is it true? How often does this kind of thing happen?

This is true. Such cases are called primary multiple tumors. In the case of his "return" it is called metachronous cancer. This, alas, is not at all a rare occurrence. Cancer is that bomb that just falls into one funnel. It is important to always monitor your health.

What external factors increase the risk of developing cancer?

First of all, this is smoking, unhealthy lifestyle, unbalanced diet, contact with chemical carcinogens at work and at home, and exposure.

In addition, the efforts of professionals who provide psychological assistance to oncological patients are already very noticeable. Oncopsychologists should not be discounted. Personally, I would recommend contacting them even prophylactically when making an oncological diagnosis.

Cancer is not a reason to fall into despair, to sign a bitter sentence. The disease, which today is one of the most common on the planet, is cured at different stages in more than 90% of cases.

How to maintain your health, whether it is possible to protect yourself from cancer, how cancer is treated in Singapore, Boris Tikhonov, Executive Director of one of the largest insurance medical organizations in Primorye, Vostochno-Insurance Alliance, spoke about this in an interview on World Cancer Day.

Boris Petrovich, is it possible to protect yourself from oncology today? Especially here, because Russia, according to the World Health Organization, occupies a completely unhonorable second place among European countries, where the highest death rates from cancer.

Unfortunately, no one is immune from cancer. The disease is not chosen by a child or an adult, rich or poor. But we should all know that cancer is curable, especially in the early stages. Modern medicine has made great strides in the diagnosis and treatment of cancer.

The latest diagnostic equipment allows you to see the insidious disease even at the zero stage. The most important thing is that a person consults a doctor in time. There is no need to wait for the manifestation of any symptoms of the disease, but to undergo diagnostic examinations in a timely and regular manner. This is a very simple rule of a civilized, careful attitude to one's own health.

By the way, this year's World Cancer Day aims to inform people as much as possible about oncological diseases, to explain that early diagnosis is needed, that cancer is curable, and in most cases it can be avoided altogether - only through a healthy lifestyle.

In 60% of cases, cancer is detected at the third or fourth stage, which makes treatment much more difficult. The earlier the disease is detected, the greater the chance of a complete cure.

Does the compulsory health insurance policy allow you to undergo the necessary examinations?

The Primorsky Territory has a Territorial Program of State Guarantees for the Provision of Free Medical Care. The program describes in detail all types and volume of medical care that are provided free of charge under the CHI policy.

Boris Petrovich, but everyone knows how difficult it is to get an appointment with a doctor: eternal queues, the problem of making an appointment, and even try, find a good doctor And not only professionally, but simply humane, sympathetic. Therefore, people put off a visit to the doctor, literally, until the last.

I agree, there are problems. But we are trying to do everything so that people insured by Vostochno-Insurance Alliance receive the medical services required under the policy on time and of good quality. This is our top priority.

If a person believes that his rights have been violated, if some kind of disputable situation has arisen, you can always call our specialists. The hotline is open 24/7. Call: 244-68-17 - expert doctors are available 24 hours a day.

If you want to be healthy, go through regular diagnostic examinations every year. This is especially important for those who are at risk: with aggravated heredity (relatives had cancer), workers in hazardous industries, as well as all people over 40 years old, when the threat of oncology increases sharply.

Is it important for the diagnosis and treatment of society's attitude towards this disease?

I think it's very important. First, society must force the state to regulate the sale of cigarettes and ban smoking in public places. Not only smokers, but also passive inhalers of tobacco smoke can suffer from it.

In countries where such policies are actively pursued (such as the United States), the incidence of lung cancer, the most devastating type of cancer, is declining. In Russia, steps are also being taken in this direction, for example, each pack of cigarettes now has a simple and understandable inscription: “smoking kills”.

The cure for cancer was invented in 1978

Who gets cancer and why? How exactly does this disease kill? Is it possible to recover from it? Should a patient at an oncology clinic know their diagnosis? Oncologist Alexander Lyubimov answers these and other questions.

Alexander Lyubimov, Doctor of Biological Sciences.

He graduated from the Faculty of Biology of Moscow State University in 1974. For almost 20 years he worked at the Russian Cancer Research Center. N.N. Blokhin, dealing with the mechanisms of tumor invasion and obtaining monoclonal antibodies for the diagnosis of colon and breast cancers.

Since 1993 he has been working at Cedars-Sinai Medical Center (Los Angeles, USA). Director of Ophthalmological Laboratories, Professor of Biomedical Sciences, Professor of Medicine at the University of California, Los Angeles. Member of the editorial boards of 10 international scientific journals.

The body against itself

Many circumstances interfere with success, but I would like to highlight three main ones.

1. The disease-causing principle is our own cells (and not viruses or bacteria that the body has learned to deal with over the millennia), which, due to genetic changes, began to divide uncontrollably in some organ.

They do not radically differ from normal cells, especially from intensively renewing ones (blood cells, intestines), which also die under classical chemotherapy methods, which leads to serious side effects.

In addition, tumor cells are heterogeneous, that is, they differ in their properties from each other. In the fight against the immune system of the host organism and overcoming the attacks of chemotherapy on cancer during treatment, selection (selection) of new variants of tumor cells occurs, which become more and more aggressive and resistant to adverse conditions, in particular, to drug effects.

Therefore, in oncology, the most effective treatment of malignant tumors is through a combination of surgical and (or) radiation and drug treatment - the so-called combined treatment. Its particular type is combined drug therapy (chemotherapy), which combines the use of several drugs at once, aimed at different aspects of the life of tumor cells to enhance the effect.

Melanoma on the face. Photo: happydoctor.ru

2. According to the rules of the famous British pathologist Leslie Foulds, which are basically confirmed by all the experience of oncology, all malignant tumors are individual, just like people are individual. Therefore, even morphologically similar forms of cancer in different people can develop differently and also differently respond to treatment.

In other words, real success in the treatment of cancer must bring an individual approach when treating a patient. Particular attention has recently been paid to personalized medicine, when the doctor should ideally first obtain data on a particular tumor in a particular patient, including detailed information about the genetic status of the tumor, the levels of various marker proteins, as well as proteins that are responsible for cell resistance to chemotherapy.

3. The most unpleasant properties of malignant tumors for treatment and prognosis are invasive growth and, especially, metastasis. Unlike benign tumors, which grow expansively, that is, in the form of a compact node, pushing aside normal cells, malignant tumors grow into the tissue of the organ in which they originated (invade).

This means that cancer cells can "eat away" the surrounding normal tissue and penetrate far from the primary tumor site. In this case, invasion can occur both in groups of cancer cells and in single cells.

This makes it difficult to determine the boundaries of the tumor for surgical removal, so doctors often have to remove not only the visible tumor node, but also part of the normal tissue adjacent to it. Sometimes this cannot be done without serious consequences, such as in the case of brain tumors.

But the most dangerous property of cancer cells is their ability to pass through the walls of blood and lymphatic vessels and enter the bloodstream and lymph. Further, they are able to survive in this environment, move to another place, again penetrate the tissue of a healthy organ and begin to grow in a new place, forming new tumor foci.

This process is called metastasis and is the main stumbling block to the success of the treatment. If this happens, doctors cannot always find all the "parts" of the tumor until they have grown to a certain size, and are forced to resort to systemic treatment with radiation to large areas of the body and chemotherapy.

Of course, about 10 million new cases are registered every year (the aging of earthlings contributes to this), but almost 30 million winners are also impressive. Forecasts for cancer growth are still disappointing (12% of all deaths), but the development of early diagnosis (more than 90% cure in the early stages) and new methods of treatment that are becoming cheaper, can seriously change the course of our fight against this disease.

Modern methods of treatment

Recently, more and more attention has been paid to the identification and characterization of tumor stem cells, and the search for ways and drugs for their targeted destruction, bypassing or suppressing the mechanisms of their drug resistance. Increasingly, biological therapies are being used, for example with anti-cancer antibodies.

They react with specific proteins (receptors) on the surface of tumor cells, which allow them to reproduce better and/or faster. Binding of an antibody (eg, Herceptin/Herceptin for some breast cancers, or Avastin for colon and rectal cancers) blocks the receptor and results in slowing or even stopping the growth of the cancer.

Biotherapy can sometimes be used alone, but more often it is used in combination with other treatments. Another promising area of ​​treatment is blocking the growth of blood vessels that feed the tumor, without which its growth slows down significantly.

Finally, one of the hottest areas of cancer research is the development of targeted drug delivery. Ideally, it should target the drug directly to the tumor (as opposed to conventional chemotherapy) using cancer cell surface proteins as targets for delivery systems.

In this regard, special attention has recently been paid to nanotechnology. With their help, systems are being developed that can selectively deliver drugs to tumor cells, while sparing normal ones, which makes it possible to increase the dose without increasing side effects.

These new systems are complex and high-tech, which is reflected in the cost of production. However, encouraging results in animals and the introduction of the first nanodrugs into the clinic allow us to hope that the large-scale use of a new generation of anticancer drugs is not far off.

Thanks to scientific and technological progress (including in the field of medicine), people began to suffer less from infectious diseases, famine and natural disasters. Life expectancy has increased, but at the same time, the risk of getting cancer at least once in a lifetime has also increased.

This is a natural process: as we age, damage to our DNA accumulates, and such changes lead to the onset of cancer. But we have learned how to diagnose cancer in a timely manner, more precisely, we have created many screening methods that allow us to recognize a tumor even before it appears. All this became possible thanks to new methods of imaging and pathomorphology.

Yes, of course, diet, lifestyle and environment together have a huge impact on the risk of malignant tumors - smoking, for example, is responsible for more than 25% of all cancer deaths.

But this does not mean at all that cancer is a modern and man-made disease. There are a lot of natural, non-human causes of cancer: every sixth case of cancer is caused by bacteria or viruses.

Let's face it, cancer treatment, whether it's chemotherapy, radiation therapy, or surgery, is no walk in the park. Side effects can be quite unpleasant, after all, a treatment that is supposed to kill cancer cells will inevitably affect healthy cells too.

Sometimes, unfortunately, neither method works. We know that it is very difficult to cure advanced cancer that has already spread throughout the body. In such situations, therapy provides temporary relief of symptoms and even prolongs life, but does not completely eliminate cancer.

Surgical treatment of cancer is still most effective in situations where the diagnosis is made early enough that surgery can still be performed. Radiation therapy also plays a huge role in the fight against cancer.

Online claims that “chemotherapy is only 3% effective” are false, as are the assumptions that chemotherapy “causes cancer.”

It is important to keep in mind the ever-increasing number of cases of successful chemotherapy. For example, today more than 96% of men with testicular cancer recover, and in the 1970s this figure did not exceed 70%.

And all this thanks to the discovery of a drug that we today call "cisplatin". Three-quarters of children diagnosed with cancer today are still alive, and in the 1960s no more than 25% of those with cancer survived.

We know we have a long way to go before there is a safe and effective treatment for all types of cancer. So far, no such cure exists, and it is important that the expectations of doctors, patients, and their families are realistic, especially when it comes to complex cancer cases.

Sometimes it makes more sense to focus on therapy that reduces pain and other symptoms of cancer rather than trying to cure the disease. Maintaining a balance between the quality of life and its duration is one of the main issues in the fight against cancer, and each patient must find the answer to it on his own.

Why does a person get sick?

What are the causes of cancer? Or there are no reliably established reasons - only hypotheses? Is there an opportunity to protect yourself, to minimize the risk?

As for the causes of cancer, the question as a whole remains open. There are many hypotheses, but not all can be tested on people. Cancer at the molecular level is the result of mutations (changes in genetic material or levels of production of certain proteins) in certain cells of the body. At the same time, such cells lose control of reproduction and begin to divide uncontrollably.

Growth of a benign and malignant tumor: in the second case, infiltration of surrounding tissues with tumor cells. Photo: anticancer.ru

These cells, in the process of selection for survival inside the body, gain an advantage over normal cells, since they have reduced requirements for growth factors in the environment and resistance to adverse conditions.

Unlike normal cells, they often cannot perform functions useful for the body, do not enter into strong contacts with each other and with surrounding normal cells, and only multiply. Thus, they behave "asocially".

Oncogenic (tumor-causing) mutations in the genetic apparatus of cells can be caused by various chemicals that can lead to the formation of tumors (such substances are called carcinogens), and certain viruses, as well as ultraviolet radiation and ionizing radiation.

The theory of chemical carcinogenesis implies that cancer is caused by exposure to environmental chemicals, many of which, alas, are man-made (for example, aniline dyes).

The mechanism of their action is apparently the same - the occurrence of genetic changes that violate the control of cell growth. There are quite a lot of known chemical carcinogens and they are very diverse in structure. These can be complex organic molecules such as polycyclic aromatic hydrocarbons or simpler molecules, for example, benzidine, arsenic and its compounds, benzene, some metals (nickel, chromium, etc.) and their compounds, natural or synthetic fibers (for example, asbestos) and other substances.

Carcinogens are present in coal tar and tar, in the exhaust gases of gasoline and diesel engines, and in tobacco smoke. They are present in a number of industries, such as, for example, the production of certain dyes, in the rubber, tanning, foundry, coke chemical or oil refining industries. Carcinogenic substances can be found in food and cosmetics.

Not only chemical carcinogens, but also some viruses can cause tumors in humans and are therefore called oncogenic viruses. Up to 15% of human tumors are of viral origin. One of the first oncogenic viruses (Rous sarcoma virus) was isolated over 100 years ago by Peyton Rous.

This theory had many opponents, so that Rous himself, receiving the Nobel Prize at the age of 87, noted as his main merit not the discovery of the virus, but the fact that he managed to live up to its official recognition (in fairness, it should be clarified that he was nominated for 40 years!).

Several types of human oncogenic viruses are now well studied. Examples include papillomaviruses and hepatitis viruses. Papillomaviruses can be sexually transmitted and cause benign papillomas of the respiratory and genital organs, as well as (in a small percentage of those infected) cervical cancer.

Hepatitis B and C viruses lead to hepatitis (inflammation of the liver), but in a small percentage of cases, chronic infection leads to liver cancer. The hepatitis C virus spreads most often through the blood, so the risk group includes, first of all, drug addicts, as well as people who receive frequent blood transfusions. Apparently, some leukemias are also of viral origin.

Ultraviolet radiation can contribute to the development of skin cancer. This is often seen in farmers and fishermen exposed to prolonged exposure to sunlight. Ionizing radiation (eg, x-rays, gamma rays, charged particles) can also cause cancer.

Its carcinogenicity has been shown in epidemiological studies conducted among various populations exposed to radiation for medical reasons, in nuclear industries, during testing of atomic weapons, as a result of accidents at nuclear power plants and, finally, after the atomic bombing of Hiroshima and Nagasaki.

Thus, a variety of factors can cause cancer. However, it is necessary to point out that the effect of the oncogenic factors listed above on a person is of a probabilistic-statistical nature, that is, the presence of an effect does not at all mean the indispensable development of a malignant tumor in this person.

To realize the effect of a carcinogenic factor, be it a chemical, a virus or radiation, additional influences are needed, and the final result of the carcinogen-organism interaction depends on a number of known and unknown factors.

It has long been observed that in older age groups the incidence of cancer increases. They tried to explain this by the accumulation of adverse genetic changes with age, and there was even a theory about the constant occurrence of small tumors, with which the body is able to cope for the time being.

However, these theories have not received serious experimental confirmation, although the accumulation of breakdowns with age is usually recognized. In general, important mechanisms of cancer occurrence are open, but many details of this multistage process remain unsolved and require further study.

Is it possible to defend?

How can cancer be prevented? Knowing the factors that cause the formation of malignant tumors helps to find ways to reduce the risk of disease by removing these factors or reducing their exposure.

Some industries are known to use or produce tumor-promoting substances. In these cases, they try to make industrial cycles closed, limit the duration of shifts, use more efficient air and emission filters, etc.

The United States and Europe have long banned the construction of houses using asbestos as a building material, because asbestos dust can cause one type of cancer. The design of automobile engines provides for the reduction of harmful emissions containing carcinogens.

In recent years, antiviral vaccines have been used to prevent infection with certain oncogenic viruses. For example, the papillomavirus vaccine is given to girls to prevent them from developing cervical cancer in the future.

Exposure to ultraviolet radiation resulting from frequent exposure to bright sunlight, especially in the middle and southern latitudes, as well as abuse of solariums increases the risk of skin cancers, which can also be easily avoided.

Careful control of exposure to which workers at nuclear power plants and other nuclear industries may be exposed dramatically reduces or eliminates the risks of developing various tumors from ionizing radiation.

An important role in preventing the development of certain tumors is played by the nature of nutrition. For example, excessive consumption of fats, especially animal fats, should be avoided and calorie intake should be reduced. Obesity is a major risk factor for uterine cancer.

Excess consumption of animal fats and meat increases the risk of colon cancer. On the contrary, eating plant foods, especially "green-yellow" vegetables, with reduced consumption of meat, especially "red", reduces the risk of developing colon cancer and a number of other tumors.

Many people have a severe vitamin D deficiency, which can also contribute to the development of cancer. Therefore, a balanced diet with a minimum of animal fats and processed meats such as hamburgers, but with a large amount of vitamins, vegetables and fruits can reduce the risk of cancer.

Finally, the most well-known factor contributing to the development of cancer, and not only lung cancer, is smoking. Tobacco smoke contains dozens of different carcinogens. Available data on the dangers of smoking confirm an increased risk of cancers of the breast, intestines, stomach, bladder, kidney, etc.

Moreover, not only active, but also passive smoking is dangerous: the risk of lung cancer in non-smoking women whose husbands smoke increases by 30%. Therefore, in many developed countries, there are powerful campaigns for smoking cessation and smoking bans in public places.

Statistics show that some forms of cancer have gone down in countries where anti-tobacco laws are in place. In Russia, unfortunately, this is still a very serious problem affecting not only adult men, but also women and children.

Another factor that needs to be dealt with is excessive consumption of strong alcoholic beverages, which increases the risk of developing cancer of the oral cavity, esophagus, liver and some other organs. Stopping alcohol abuse, along with quitting smoking, will help to significantly reduce cancer incidence.

In general, the problem of reducing the risk of cancer is very serious, and it must be addressed in a comprehensive manner, not only by doctors, but also by society as a whole.

Get a medical checkup!

In this regard, the problem of early diagnosis should also be mentioned. It's no secret that the disease at an early stage is always treated faster and more efficiently than at a later stage. Therefore, it is impossible to neglect, albeit meager (this word will not work for early diagnosis), but already available opportunities for early diagnosis.

Men over 50 years of age should regularly (once a year) do a blood test for protein content - prostate-specific antigen (PSA). If an increase in its concentration in the blood (above the normal 4 ng / ml) is recorded in two studies close in time, you should immediately consult a doctor. Early detection of prostate cancer is the key to a full recovery.

The same applies to women who have a chance of detecting a breast tumor at an early stage if they regularly visit a gynecologist, and after 40 years also regularly do mammograms. After the age of 50, it is also recommended to do a colonoscopy every 3-5 years, (optical examination of the large intestine), so that the tumor can be detected in the early stages. Unfortunately, this practice is not common everywhere.

The advantage of early diagnosis is evidenced by a well-known fact from the history of Japanese medicine. Due to lifestyle habits, including diet, stomach cancer is common in Japan. They had a national cancerophobia for a long time because of this.

However, the healthcare system has found the answer. Diagnostic buses with the necessary equipment began to travel throughout the country and check the population even in villages. At the same time, they were able to identify many asymptomatic cancers and then treat patients.

How does a malignant tumor behave?

How does cancer kill a person? Cell regeneration - why does it lead to death?

In itself, the degeneration of cells does not lead to death. It leads to the consequences of tumor growth, which depend on many causes and on the type of tumor. The most common cause is an associated infection (often pneumonia) associated with suppression of the immune system by the tumor. This phenomenon is well described, but the reasons are not fully understood.

In the case of leukemia (sometimes incorrectly referred to as "blood cancer"), tumor cells that replace normal cells in the bone marrow are unable to perform protective functions, which leads to a decrease in immunity and the development of infections.

Radiotherapy and chemotherapy, by killing cancer cells, have a negative effect on healthy ones, which also undermines the body's resistance to infections. Acute hemorrhage, occlusion of blood vessels by thrombi and pulmonary insufficiency can also lead to death in almost 20% of cancer patients.

Invasion and, as a result, tissue destruction (bones, liver, brain, etc.) lead to the death of 10% of patients. Some tumors, such as colon cancer, can cause severe and sometimes fatal anemia due to chronic hemorrhage. e.

What is the first thing to be afraid of?

What types of cancer are the most common/most dangerous? Which are the easiest to treat?

In connection with the aging of the population, as well as the improvement of early diagnosis, prostate cancer in men has come out on top in terms of incidence. There is an opinion among oncologists that all men can get this cancer, but not all live to see it.

If we talk about tumors that are not related to sex, lung cancer ranks first in terms of incidence. Often there are cancers of the colon and rectum. Somewhat less often, people get bladder cancer, melanoma, non-Hodgkin's lymphoma, kidney cancer, leukemia.

Tumor of the lung. Color electron micrograph. Photo: Moredun Animal Health LTD

Mortality from these diseases varies greatly. Lung cancer is the most common killer (more than deaths in the US in 2010), followed in descending order by cancers of the colon and rectum, breast, pancreas, prostate, leukemia, etc.

The most difficult to treat is pancreatic cancer. Only 5% of patients survive 5 years. However, in general, most patients die from lung cancer, primarily because of its prevalence.

Some skin cancers (basaliomas) rarely metastasize and are easily cured with conventional surgical removal. As mentioned above, Burkitt's lymphoma, which is mainly common in Africa, is well treated, as well as chorionepithelioma and Hodgkin's disease.

In these cases, conventional classical chemotherapy is sufficient. It is important to know that many malignant tumors in the early stages (I-II) have a high probability of complete cure, in particular, breast cancer.

Does the patient have a right to know the diagnosis?

In America, a person is immediately informed of the diagnosis, in Russia it is believed that the patient still does not understand medicine, so you just need to obediently follow the doctors' instructions and not try to understand what is happening to him. Which approach is more correct?

Interesting data on this issue regarding the US and Russia are presented here. Indeed, in the United States, not only relatives, but also the patient is informed of the diagnosis of cancer. Firstly, doctors cannot hide the diagnosis, otherwise they may be sued.

Secondly, patients are recognized the right to full information so that they can put their affairs in order, legal, property, etc. However, this can adversely affect the mental state of the patient, cause depression, sometimes refusal of treatment, attempts to be treated non-traditional methods, thinking that conventional medicine will not save anyway.

In Russia, patients are often (but not always) not told that they have cancer, not because "the patient does not understand medicine." The ethical side of this issue is much more subtle. Firstly, such a diagnosis, as mentioned above, can adversely affect the mental state of the patient, up to suicidal moods and real suicide attempts. In the latter case, the belief that cancer is usually incurable plays a role.

Photo: Evgeny Kapustin, photosight.ru

As was said in an interview with Russian oncologists, cancer is often viewed in society not as a diagnosis, but as a sentence. Moreover, some even believe that the disease was sent to them as a punishment, which is completely wrong.

Secondly, it is believed, although it has not yet been scientifically proven, that patients who tune in to defeat the disease more often defeat it. And if there is even a little bit of hope, faith in victory remains. "Fighters" endure therapy even better than people who have resigned themselves to their fate. A detailed and very objective analysis of these problems can be found at this link.

To help patients, both in the fight against the disease and during the rehabilitation period after operations, many oncology centers employ full-time psychologists. So, for example, in the Moscow Cancer Center. N. N. Blokhin, psychologists have been helping patients for several decades.

Naturally, where the rules oblige doctors to report the diagnosis not only to close relatives, but also to the patients themselves, this issue goes to another plane and comes down to persuading the patient to start the fight against the disease in the same team with the doctors and in a clear explanation of the treatment strategy and the chances of recovery .

It is the doctor-patient tandem that must decide the outcome of the disease. Therefore, oncology, especially for children, requires enthusiasm and a high degree of empathy. As we can see, both approaches have a right to exist;

Where and with whom to be treated?

- What is the fundamental difference in the approach to treatment in America and in Russia?

As far as I know, there is no fundamental difference in approach; it would be strange enough if it was. And the structure of the disease in terms of localizations is generally similar. However, the practical difference in treatment may be significant in favor of the US for a number of reasons.

These include relative difficulties in Russia, especially in the periphery, with new generation drugs, sophisticated diagnostic and treatment equipment, lack of awareness of doctors about new methods of treatment (this may include problems with English), a potential lack of experience in certain operations, etc. d.

Although the number of oncologists and radiologists of the population in Russia and the United States is approximately the same. These considerations, of course, do not apply to major cancer centers, which in Russia provide treatment at the world level.

This is a very difficult and rather individual question. If there is a recommendation, it makes things easier. Treatment should only be carried out in a specialized clinic (and not in a regular hospital). There, doctors are “sharpened” for oncology, both for diagnosis and treatment.

The choice of physician may be dictated by a variety of reasons; everyone can name ten at once. It is important that the doctor has experience or be a specialist in this localization, and not an oncologist "in general"; in oncology centers this is usually the case, but in polyclinics the situation is different.

Chemotherapy. Photo: zdorovieinfo.ru

Doctors usually treat according to standard schemes, so everyone works about the same. An important point is adequate contact with the patient and relatives. A competent doctor will reveal all the cards, tell the tactics of treatment and outline the possible consequences.

The confidence and logic of the doctor should show the patient the competence of the doctor: these are important elements of trust. The doctor's ability to answer calmly, rationally, and persuasively to naive, stupid, and sometimes aggressive questions also adds credibility.

According to Dr. Bogdanova (MNIOI named after Herzen), the patient must feel the empathy of the doctor in order to believe him. And we should not forget that the patient never interferes with enlightenment before meeting with the doctor due to the seriousness of the disease.

On the Internet there is a lot of quite professional information on all types of tumors, as well as support groups where patients, especially cured ones, share their personal experiences. Finally, no one canceled another medical opinion, and in such serious cases one should try to get it as far as possible.

Who speaks of miracles?

Have there been cases of inexplicable / miraculous healing in your practice?

The possibility of self-healing from cancer (“spontaneous regression” of the tumor) is a very old and controversial issue. If, God forbid, someone's relative gets sick, these people immediately begin to hear stories about miraculous healing, as well as about healers, grandmothers, etc.

In modern oncological literature, cases of self-healing are described, but they are extremely rare, about 1 of cancers. However, some tumors are more likely to spontaneously regress (resolve) than others, such as kidney cancer. Many oncologists, however, never see such cases in their lives.

Academician N. N. Blokhin, answering the question whether he had met such cases (and he had a photographic memory), said unequivocally that he had not. At the same time, several cases of this kind were misdiagnosed, or slides with sections of tumor tissue (biopsy material) were mysteriously lost.

The reasons for the self-healing, if any, are completely unclear, which leaves room for the imagination, especially among charlatans and dilettantes, in particular, writing on social networks. The main hypothesis can be considered the activation of the body's immune system, which occurs as a response to the strong difference between the cells of this tumor and normal ones. The psychosomatic component is also considered.

The danger of faith in self-healing is that it greatly helps all sorts of charlatans who prepare all sorts of concoctions or “heal” with the help of “astral communication”. General advice to all sick people - never resort to the help of healers and parapsychologists.

They have not yet helped anyone recover from cancer, but in many cases they “helped” patients turn to professionals not at stage I of the disease, but at stage III or IV. There are many recent examples of this from the life of "stars" (for ethical reasons I do not want to name the deceased).

From marijuana to coffee enemas, the internet is teeming with videos and stories of healing with natural "miracle" cancer drugs.

But these supernatural healings unfortunately use the same supernatural evidence: YouTube videos and blog posts instead of clinical studies and scientific journal publications.

In most cases, it is not even possible to assess the credibility of a healing video or post. We do not know anything about the diagnosis, the stage of the disease, the method of treatment - we do not even know whether those who are called patients in the commercials actually had cancer.

Usually we hear about such remedies only stories of healing - but where are all those who tried, but did not help them? Or did it help, but it was already too late? The dead cannot talk, so people who talk about magical cures often create an unrealistic picture, wittingly or unwittingly juggling the facts and presenting the “miracle tincture” as almost a panacea.

These standards must be met by all drugs used to treat malignant tumors.

This does not mean that there are no sources of medicines in nature. Many drugs, from aspirin to penicillin, have been derived from natural raw materials such as willow bark or mold. And the well-known antitumor drug paclitaxel was originally isolated from the bark and needles of the Pacific short-leaved yew.

But this is not at all the same as shouting from all angles: "BICK THE BARK TO CURE CANCER." The drug becomes effective only after many stages of purification and long-term clinical studies, during which scientists understood at what dose this drug is effective and safe.

Of course, people want to fight their disease with all existing and non-existent methods, and it is perfectly normal that they grab at the slightest hope and often believe everything.

Wikipedia provides a stunningly comprehensive list of ineffective bogus anti-cancer drugs that everyone should look into. Check, maybe the "newest remedy for all types of cancer", offered to you by the next "folk healer", is in it a long time ago.

Myths and fears

- What are the causes of oncophobia? Are they the same or different in America and Russia?

In my opinion, the main reason is the lack of education of the population. Routine thinking plays a role in all countries, as people still often die from cancer, and therefore it appears to be a fatal disease.

Although, for example, Alzheimer's disease (a kind of senile dementia) is much more fatal. Heart attacks and strokes claim significantly more lives than cancer, but they are not so feared. All this is a lack of information.

Another ugly manifestation of oncophobia (commonly referred to as cancerophobia) is the belief that cancer is contagious. Basically, this misconception is typical of Russia. Of course, the papillomavirus that causes cervical cancer can be transmitted sexually, and hepatitis C can be transmitted through blood transfusions. However, with the exception of these cases, there is no evidence in favor of the contagiousness of cancer.

Another possible cause of cancerophobia in Russia is a consequence of the prohibition to speak the diagnosis to the patient. Therefore, if the patient recovered, then he recovered from a stomach ulcer, kidney cyst or uterine fibromyoma, but if he died, then relatives found out the true diagnosis, and often shared it with friends. Thus, in Russia for years there was an impression that one does not recover from cancer.

In the age of the Internet, people can get much more professional information than before, and almost immediately. Therefore, being afraid of cancer is pretty stupid. It is necessary, if possible, to lead a healthy lifestyle (in particular, do not smoke) and be examined regularly. Of course, in Russia and, say, in the United States, the opportunities here are unequal.

American decentralization (many specialized centers throughout the country) and Russian centralization (the concentration of such centers mainly in large cities) are completely different systems for diagnosis and treatment, with the former having many advantages.

Therefore, cancerophobia in Russia may be partly due to the fact that sick people may not have access to qualified cancer care, not to mention early diagnosis or preventive examinations. Although such centers as RONTS them. N. N. Blokhin in Moscow, work at the world level.

L Anticancer drugs and immunomodulators

Indications for use

We will not delve into the details of the biochemical processes that determine the pharmacodynamics of anticancer drugs: indications for the use of each of them are approved by clinical protocols for chemotherapy for each type of tumor, taking into account the stage of the disease, the presence of metastases and the individual characteristics of the body of a particular patient.

Major cancer drug names

It is impossible to list all the names of anti-cancer drugs currently being produced: almost fifty drugs can be used only for the treatment of breast cancer. The release form of most anticancer drugs is a lyophilizate (in vials) for the preparation of an infusion solution or a ready-made solution (in ampoules) for parenteral use. Some enzyme inhibitors and immunomodulating agents are available in tablets and capsules.

Chemotherapy protocols provide for the use of:

  • medicine for lung cancer: Cyclophosphamide (Cyclophosphamide, Cytoxan, Endoscan), Ifosfamide, Gemcitabine (Gemzar, Cytogem), Hydroxyurea;
  • medicine for stomach cancer: Etoposide (Epipodophyllotoxin), Bortezomib (Velcade), Ftorafur (Ftoruracil, Tegafur, Sinoflurol), Methotrexate (Evetrex);
  • pancreatic cancer drugs: Streptozocin, Ifosfamide, Imatinib (Gleevec), Ftorafur, Gemcitabine;
  • liver cancer drugs: Cisplatin (Platinotin), Doxorubicin (Rastocin, Syndroxocin), Sorafenib (Neskavar), Everolimus (Afinitor), Ftorafur;
  • kidney cancer medicine: Dacarbazine, Fluorouracil, Cisplatin, Imatinib, Sunitinib, Gemcitabine;
  • medicine for esophageal cancer: Vincristine, Doxorubicin, Fluorouracil, Paclitaxel, Imatinib;
  • bowel cancer medicine: Leucovorin, Capecitabine, Oxaliplatin (Carboplatin, Medaxa, Cytoplatin), Irinotecan, Bevacizumab, Cetuximab (Erbitux);
  • medicine for squamous cell cancer: Cisplatin, Etoposide, Ifosfamide, Doxorubicin, Dacarbazine;
  • throat cancer medicine: Cabroplatin, Cyclophosphamide, Dacarbazine, Cetuximab;
  • breast cancer medicines: Pertuzumab (Pieretta), Paclitaxel, Goserelin, Thiotepa, Tamoxifen, Letromara, Methotrexate, Epirubicin, Trastuzumab;
  • medicine for uterine cancer: Chlorambucil, Cyclophosphamide (Endoxan), Dacarbazine, Methotrexate;
  • drugs for cervical cancer: Cyclophosphamide, Ifosfamide, Pertuzumab (Pierrette), Xeloda;
  • medicines for ovarian cancer (carcinoma): Cisplatin, Cytoforsphan, Melphalan, Fluorouracil, Chlorambucil;
  • medicines for bone cancer (osteogenic sarcoma): ifosfamide, cabroplatin, cyclophosphamide;
  • medicine for blood cancer (acute leukemia): Cytarabine, Ibrutinib, Doxorubicin, Idarubicin (Zavedox), Fludarabine;
  • drugs for cancer of the lymphatic system (lymphomas): Bleomycin, Doxorubicin, Cyclophosphamide, Etoposide, Alemtuzumab, Rituximab (Redditux, Rituxan);
  • skin cancer drug: Fluorouracil, Melphalan, Gliosomid, Demecolcin;
  • drugs for brain cancer (gliomas, glioblastomas, meningiomas, etc.): Bevacizumab, Temozolomide (Temodal), Procarbazine, Vincristine, Cyclophosphamide;
  • medicine for bladder cancer: Cyclophosphamide, Gemcitabine, Cisplatin, Carboplatin, Methotrexate;
  • drugs for prostate cancer (prostate adenocarcinoma): Bicalutamide (Casodex), Fluorouracil, Triptorelin (Diferelin), Leuprorelin, Degarelix (Firmagon), Flutamide.

Cancer cure from Germany

The release of anti-cancer drugs (Gemzar, Alkeran, Crizotinib, Holoxan, Oxaliplatin, etc.) is carried out by many German pharmaceutical companies, including well-known ones such as Bayer and Merck.

Cancer cure from Germany Nexavar, manufactured by Bayer AG, is used to treat inoperable hepatocellular carcinoma, renal cell carcinoma, and thyroid cancer.

The company produces the protein kinase inhibitor Stivagra (Regorafenib) for the treatment of bowel cancer, as well as the radiopharmaceutical Xofigo, used in the treatment of metastatic bone cancer.

Merck launches experimental cancer drug Vorinostat (Vorinostat) or Zolinza, which is used for progressive, chemotherapy-resistant T-cell cutaneous lymphoma (approved by the FDA in 2006). The active substance of the drug is suberoylanilide-hydroxamic acid (SAHA), which inhibits histone deacetylase (HDAC). Clinical trials of this drug are ongoing and have shown activity against recurrent glioblastoma multiforme (brain tumor) and non-small cell lung carcinoma.

Cancer cure in Israel

Numerous cancer centers can provide any cancer medicine in Israel as well as patients outside the country.

One of the newest drugs used by Israeli oncologists for targeted therapy of advanced melanoma, non-small cell lung cancer and renal carcinoma - Opdivo(Opdivo) or Nivolumab (Nivolumab) - refers to a new pharmacological group of PD-1 receptor blockers. The medicine was developed by the American biopharmaceutical company Medarex and Ono Pharmaceutical (Japan), produced by Bristol-Myers Squibb (USA); approved by the FDA in 2014.

Cell apoptosis receptor-1 (PD-1) is a member of the CD28 receptor membrane protein superfamily that plays a critical regulatory role in immune T cell activation and tolerance, as well as tissue protection from autoimmune attack. Moreover, being activated in chronic infections and malignant tumors, this receptor and its ligands weaken the body's defenses. Blocking PD-1 allows the immune system to attack cancer cells. In trials, Opdivo has been shown to be effective in the treatment of metastatic advanced squamous cell lung cancer.

Recently, Russian media announced the development and decision to produce PD 1 drug, which, according to the head of the Ministry of Health of the Russian Federation, "is able to completely cure oncological diseases that were previously untreatable."

American cancer drugs

More than a decade ago, the American pharmaceutical company Bristol-Myers Squibb began developing an experimental cancer drug. Tanespimycin(Tanespimycin, 17-AAG) is a derivative of the polyketide antibiotic Geldanamycin, which has been studied for the treatment of leukemia, multiple myeloma, and kidney tumors. The drug acts by inhibiting intracellular stress protein - heat shock protein (HSP) or chaperone, which performs regenerative functions and prevents apoptosis.

Proteins that are produced by cells during stressful conditions (necrosis, tissue destruction or lysis) were discovered in the early 1960s. Italian geneticist Ferruccio Ritossa. Over time, it turned out that HSPs are activated in cancer cells and increase their survival. The heat shock transcription factor (HSF1), which regulates the expression of the genes for this protein, was also discovered. Specialists from the Whitehead Biomedical Research Institute (Massachusetts Institute of Technology) proved that HSF1 coordinates the induction of chaperones and is a multilateral factor in carcinogenesis, and deactivation of this factor stops tumor growth. Drugs that block heat shock protein are referred to as proteasome or proteolysis inhibitors.

When Bristol-Myers Squibb pulled out of Tanespimycin, a new American drug for breast cancer, lung carcinoma and angiosarcoma - Triolimus– began manufacturing the newly formed company Co-D Therapeutics, Inc. This medicine contains nanotechnology-based polymer micelles that allow multiple anti-cancer agents such as Paclitaxel, Rapamycin and Tanespimycin to be delivered in a single formulation.

By the way, since 2006 Bristol-Myers Squibb has also been releasing a nano-cure for cancer. Sprycell(Dasatinib), belonging to the group of enzyme tyrosine kinase inhibitors and intended for the treatment of lymphoblastic leukemia and skin cancer with metastases.

Nanomolar concentrations of the drug act purposefully and inhibit the growth of only tumor cells.

But back to the chaperones. In the spring of 2017, there were reports that the NII OCHB FMBA (Research Institute for Highly Pure Preparations at the Federal Medical and Biological Agency) developed and tested on laboratory rats a unique Russian cure for cancer of any kind. Its basis is a heat shock protein, which, according to the authors of the publication, has an antitumor effect ...

Russian cure for cancer

For the complex therapy of breast cancer, the Russian cancer medicine Refnot is offered, in which the active components are genetically modified cytokines - TNFα(tumor necrosis factor-alpha) and thymosin alpha-1 (lymphocyte growth factor and T-cell differentiation). It should be noted that a separate drug Thymosin-alpha belongs to the pharmacological group of immunostimulants.

BIOCAD (Russian Federation) produces anti-cancer monoclonal antibodies Acellbia(Rituximab) Bevacizumab and BCD-100, as well as an antimetabolite Gemcitar(Gemcitabine) and proteasome inhibitor Bortezomib.

The last drug under the designations Amilan-FS and Boramilan-FS is produced by F-Synthesis; entitled Boramilan Nativa company; the trade name Bortezol was assigned to this drug by Pharmasyntez, and two other Russian companies produce Bortezomib under the name Milatib.

Finnish cancer medicines

Finland is considered one of the leading countries in the field of cancer research and treatment. According to the EUROCARE-5 cancer survival study in Europe, Finland was ranked the best European country in the treatment of breast, head and neck cancer, third in the treatment of prostate cancer and fourth in the treatment of colon cancer.

Antiestrogenic drug Fareston from breast cancer in women during menopause is produced by the Finnish company Orion Pharma (Orion Pharma). It also produces an antihormonal drug for prostate cancer. Flutamide.

The Institute of Molecular Medicine of the University of Helsinki, together with the American pharmaceutical company Pfizer, are starting to develop new targeted anticancer drugs for the treatment of leukemia.

Indian cure for cancer

In the complex treatment of malignant tumors of the gastrointestinal tract can be used Suprapol(manufactured by Glerma Pharmaceuticals, India).

This Indian cancer medicine consists of the antimetabolite fluorouracil and fulvic (humic) acid, which has a number of biological inhibitory properties, exhibits adaptogenic and anabolic qualities, and promotes detoxification of the body.

In the last two decades, the antiproliferative and antitumor properties of humic fulvic acids in cancer of the liver and other organs have been intensively studied abroad. So, in 2004, a group of scientists from China Medical University (Taiwan) found that humic acid induces apoptosis of HL-60 cells in promyelocytic leukemia. By the way, a patent for the invention of a method for producing modified fulvic acid for the preparation of anticancer drugs was issued in 2008, also in China.

Chinese medicine for cancer

Many Chinese cancer medicines are herbal, and this medicine is no exception. Kanlayt- an extract from the grains of pearl barley or common busen. This cereal, a relative of corn that grows in the countries of Southeast Asia, is also called Job's tears (lat. Coix lacryma-jobi). Along with other herbs, it has always been used in traditional Chinese medicine as a diuretic, pain reliever, and antispasmodic.

In the middle of the last century, the Japanese were engaged in the study of pearl barley, and for a more detailed study of its properties by scientists from the University of Zhejiang Province

was prompted by the fact that among the inhabitants of southeast China, in whose diet this cereal is present, the incidence of cancer is the lowest in the country.

The drug KLT for parenteral use is an emulsion of lipids extracted from the grains of the plant - a mixture of saturated and unsaturated fatty acids. The drug has passed laboratory studies and clinical trials in medical institutions in China, proving its effectiveness in lung carcinoma, as well as tumors of the breast, stomach and liver.

In the description of the action of this drug, its ability to slow down the mitosis of cancer cells and the formation of blood vessels in tumor tissues is noted.

Cuban cure for cancer

According to Expert Revue Vaccines, the new Cuban cancer drug CIMAvax-EGF is Cimavax(based on the molecular complex of the epidermal growth factor EGF) is claimed as a therapeutic antitumor vaccine for progressive non-small cell lung cancer that does not respond to chemotherapy (as an adjuvant).

In five clinical trials and two randomized trials, four doses of Civamax were found to improve patient survival. The safety of this drug has also been confirmed.

The Journal of Biological Chemistry reports cancer drug trials are underway CIMAvax-EGF- in order to test EGF as a predictive biomarker of the effectiveness of this drug.

Kazakh medicine for cancer Arglabin

Arglabin, an immunomodulatory drug of plant origin, for parenteral use after radiation or chemotherapy for oncological diseases of the mammary glands, ovaries, lungs and liver, is produced in Kazakhstan.

The destruction of cancer cells and the enhancement of the biological effect of radiation therapy is provided by the arglabin compound dimetolamine isolated from the plant Artemisia glabella (smooth wormwood), which is a registered antitumor substance in the Republic of Kazakhstan.

Researchers at the International School of Molecular Medicine at the University of Ulm (Germany) are studying the antitumor potential of arglabin using prostate carcinoma cell lines. It has been proven in vivo that this substance can selectively inhibit the proliferation and reduce the viability of prostate cancer PC-3 cells, as well as initiate their apoptosis by activating cysteine ​​proteases (which leads to cell membrane damage and DNA fragmentation).

And in the research center of Wageningen University (Netherlands), they developed a new method to obtain arglabin from bitter wormwood (Artemisia absinthium), and from tansy (Tanacetum parthenium) another compound with anticancer activity - parphenolide.

Ukrainian cure for cancer

An antitumor agent of Ukrainian development, created at the Institute of Experimental Pathology, Oncology and Radiobiology of the Academy of Sciences of Ukraine - nano cure for cancer breast Ferroplat (alkylating cytostaic Cisplatin + magnetized iron in the form of nanoparticles). Currently, its preclinical studies are ongoing.

How do I get into cancer drug trials on cancer patients? When the drug is ready (passes all the required checks and execution of all the required documents), the Ministry of Health of Ukraine will prepare and publish on its official website an appropriate order indicating the medical institutions selected for conducting clinical trials of this drug and the conditions for its potential participants (having suitable for drug diagnosis and a detailed medical history with a full description of the treatment and its results).

Together, scientists of the National Antarctic Research Center and the Institute of Biology and Medicine of the KNU named after A.I. Shevchenko. During the Antarctic expeditions 2013-2015. At the Akademik Vernadsky station, microorganisms living on soil, mosses and lichens adapted to low temperatures were studied as potential sources of compounds with biologically active properties. And among the cultures of micromycetes and bacteria discovered by microbiologists (more than three dozen in total), suitable “candidates” were found. According to the Ukrainian Antactic Journal, these are microscopic gelotian fungi of the genus Pseudogymnoascus pannorum (surviving in the cold due to the accumulation of lipids in cell membranes) and Zygomycete Mucor circinelloides (known for its ability to genetic transformations).

What is a digital cancer cure?

It is an experimental drug for cancer, created with the help of computer technology, which makes it possible to combine and compare complex sets of molecular, biochemical and clinical data that represent the disease from all sides. In addition, the drug development cycle is reduced several times.

Biotechnology company BERG Health has created a computer program (Interrogative Biology AI platform) to develop drugs for cancer using artificial intelligence. One drug in particular, BPM 31510, has entered phase II trials to study its efficacy in the treatment of pancreatic cancer.

Another digital cure for cancer is the new drug BPM 31510-IV for the treatment of glioblastoma multiforme (a type of brain cancer). To clarify the exact mechanism of its action, the drug will be tested in patients whose standard treatment is carried out with the use of recombinant monoclonal antibodies, in particular, Bevacizumab.

Many IT professionals predict that the Interrogative Biology AI platform could revolutionize the pharmaceutical industry.

Does vitamin 17 exist?

Vitamin 17, other names - Laetrile, Letrile, Amygdalin, was produced in the USA and was presented as a cure for cancer. In fact, liquid Laetrile B 17 was part of the Budwig diet for cancer patients (which will be discussed below) - as a dietary supplement.

After repeated cases of Americans being poisoned with Laetrile, the FDA began prosecuting "natural medicine" clinics that used the drug. In late 2012, the American Cancer Society stated that (quote) "existing scientific evidence does not support claims that Laetrile or Amygdalin are effective in treating cancer."

Drugs other than anticancer drugs

Adjuvants that are proposed for use in combination therapy of oncological diseases do not belong to anticancer drugs:

Timalin (bovine thymus extract) can be used to maintain immunity during long-term use of antibacterial drugs, courses of chemotherapy and radiation.

ASD (Dorogov's antiseptic stimulant, produced by high-temperature processing of meat and bone meal) is a modified Russian-made biostimulant used in veterinary medicine. According to the patent, it can be used to activate the general and local metabolism.

Thiophane is a phenolic antioxidant produced by the Russian Federation, containing hydroxyphenyl-propyl sulfides and a polymer and food stabilizer (CO-3). It acts as an angiprotector, that is, it improves the rheological properties of the blood and reduces the risk of blood clots.

Creolin - antiseptic for disinfection; can be used externally for mycoses.

Krutsin - official production has long been discontinued.

Folk cures for cancer

Some, faced with an oncological diagnosis, decide to use the so-called traditional cancer cures. Do such miracle cures even exist?

For example, there are rumors that soda as a cure for cancer cures oncology ...

Now expelled from the Italian Medical Association, the Italian oncologist Tulio Simoncini at one time came up with the idea of ​​​​the fungal origin of cancer, and he assured everyone that cancer was provoked by the fungus Candida albicans, which colonizes the human body (and even wrote the book Cancer is Fungus about this). For the fact that he treated cancer patients with injections of a solution of sodium bicarbonate (soda), and did not prescribe the necessary drugs for cancer, he was deprived of the right to practice medicine. And when one of his patients died, Simoncini was put on trial.

Chaga (birch fungus), celandine grass (especially for colon cancer), garlic, green tea, ginger root and turmeric are considered folk remedies for cancer.

Selenium (Se) is able to inhibit the growth of thyroid tumors, thanks to the optimization of the immune system and antioxidant properties (American oncologists recommend that their patients consume 200 micrograms of selenium daily).

The perennial herb aconite (wrestler) used in homeopathy is poisonous, but, as recent laboratory studies at the Hospital of Traditional Chinese Medicine (Lishui, Zhejiang Province) showed, the poisonous alkaloid of this plant - aconitine - inhibits the growth of pancreatic cancer cells and activates them apoptosis (the study was conducted on mice).

How can black elderberry (Sambucus nigra) help with cancer? Elderberry contains anthocyanins, flavonoids, other polyphenols and vitamins A and C, which give its berries medicinal properties, in particular, antioxidants. Several physiological and biochemical processes in the body contribute to the formation of free radicals. Oxidative reactions can cause abnormal cell mitosis and the appearance of tumors that can become malignant.

Once, for lack of medicines, kerosene (an oil refining product) was used for general infection (for disinfection), arthritis and radiculitis). Perhaps the merit of kerosene (taken orally) is the destruction of bacteria and fungal infections, which in cancer reduced the infectious burden on the immune system.

Fly agaric, pale grebe and cancer

The red fly agaric (Amanita muscaria) and its closest “relative”, the pale grebe (Amanita phalloides), belonging to the deadly poisonous amanite mushrooms, contain amatoxins α- and β-amanitin. In classical homeopathy, Amanita phalloides is used as a remedy for the fear of death...

The mechanism of the toxic effects of amatoxins on the human body is associated with the inhibition of a vital enzyme in the synthesis of cellular proteins - RNA polymerase II (RNAP II). Interacting with this enzyme, α-amanitin prevents the translocation of RNA and DNA, resulting in the cessation of metabolism in cells and its death. When all this happens with tumor cells, where, as it turned out, RNAP II activity (due to increased expression of tumor HOX genes) is higher compared to healthy cells, fly agaric or toadstool toxin acts as an anticancer agent. At the same time, α-amanitin, affecting atypical cells, does not cause serious consequences for healthy cells.], ,

Hemp and its oil

Hemp seed (Cannabis sativa) provides not only a drug, but also an oil, which is considered an effective complementary treatment for cancer, stopping the growth of malignant tumors.

Hemp oil contains cannabinoids (phenol-containing terpenoids), one of which, cannabidiol, binds to specific ones that are found in the central nervous system, lungs, liver, kidneys, hematopoietic and immunocompetent cells (macrophages, T- and B-cells of the immune system). Due to its blocking effect on the inhibitor of DNA-binding protein ID-1 (stimulating growth, angiogenesis and neoplastic transformation of cells), cannabidiol reduces its expression in cancer cells.

This has been proven by a number of studies, and today hemp oil includes such anti-cancer effects as preventing the appearance of new blood vessels in the tumor and the spread of cancer cells to neighboring tissues, as well as stopping the division of atypical cells and starting the process of their lysosomal "self-digestion" - autophagy. This applies to malignant neoplasms of the lungs, prostate and pancreas, colorectal carcinoma and ovarian cancer, leukemia and lymphomas.

Flax oil in the diet of cancer patients

Linseed oil (linseed oil) contains a lot of unsaturated fatty acids: linolenic (ω-3), linoleic (ω-6) and oleic (ω-9). It also contains alpha and gamma tocopherol and selenium. Selenium was mentioned above, but fatty acids should be precisely unsaturated, since, according to the theory of the famous German pharmacologist and nutritionist Johanna Budwig, author of the diet for cancer patients, the causes of many forms of cancer lie in the imbalance of polyunsaturated and polyunsaturated fatty acids - with the predominance of saturated.

Experts from the American Institute for Cancer Research support the opinion that flax oil is certainly useful for cancer patients, but it cannot cure oncopathology.

Where can I get Brazilian wasp venom?

Polybia wasp (Polybia paulista) lives in the tropical regions of Argentina, Paraguay and is common in Brazil

The venom of the Brazilian wasp contains peptide toxins - polybins (Polybia-MP1, etc.), which, as biochemists from Sao Paulo State University (Brazil) and the British University of Leeds have found out, bind adhesively to phospholipids of cell membranes, damage them and penetrate into cancer cells.

And as a result of the subsequent necrosis of the cytoplasm and the chemical destruction of mitochondria, a decrease in tumors is observed - due to the inevitable death of its cells.

How do cancer drugs work?

When asked the question - is there a cure for cancer? - then, obviously, they mean a remedy that can destroy the tumor and make damaged cells healthy. There is no such drug yet, and most of the drugs that are currently used by oncologists in cancer chemotherapy (they are called anti-blastoma cytostatics and cytotoxins) are aimed at slowing down the mitosis of tumor cells, leading to their programmed decay. Unfortunately, these drugs do not act selectively (only on tumor cells), and normal cells are also affected.

A universal cure for all types of cancer - despite the occasional loud claims from some pharmaceutical companies - is also not yet available. The fact is that cancerous tumors of various organs are formed, grow and react to drug exposure in different ways, and this depends on many factors that are difficult to take into account in a single drug.

However, in almost all types of malignant neoplasms, polyfunctional alkylating drugs (inhibitors of DNA replication) are used. This is one of the main and most numerous groups of anticancer agents. Depending on the mechanism of action, cytostatic drugs for cancer may be referred to as antimetabolites (Methotrexate, Ftorafur, Gemcitabine, etc.), plant alkaloids (Vincristine, Vinblastine, Paclitaxel, Docetaxel, Etoposide) and antitumor antibiotics (Bleomycin, Doxorubicin, Mitomycin).

For targeted (targeted) therapy, other drugs are used. First, they must reduce the number of tumor cells without affecting normal cells, especially immune ones. Secondly, the immune system needs to be strengthened, especially its cellular link. To achieve the first goal, there are drugs that have an inhibitory or blocking effect on specific cancer genes or enzymes in the human body that promote the growth and survival of tumor cells. These are enzyme inhibitors (Imatinib, Sunitinib, Bortezomib, Letromara, Regorafenib, etc.) and monoclonal antibodies (Alemtuzumab, Bevacizumab, Rituximab, Trastuzumab, Keytruda(pembrolizumab), Pierrette(Pertuzumab). A number of antitumor hormonal agents (for example, Triptorelin, Goserelin, etc.) are used for hormone-dependent types of cancer. And to help the immune system deal with mutant cells, oncologists prescribe immune-modulating drugs (although there is controversy about how effective they are).

The most expensive cancer drugs

Cancer is a cruel disease that affects millions of people every year. And in order to overcome their illness, they are forced to pay fabulous money for the majority for the most expensive cancer drugs. From a business point of view, oncology drugs are the most reliable guarantee of high profits for pharmaceutical companies...

Many new drugs target specific types of cancer and are very expensive. For example, the price of 40 mg of the drug Opdivo(nivolumab) 40 mg. - more than $900, and 100 mg - over $2300. The price of one package of medicine Zolinza(in a package of 120 tablets) is about $12 thousand, that is, each tablet costs the patient $100.

When will a cure for cancer be invented?

"Cancer treatment is difficult and the biological changes in cancer types are profound and a big challenge with all the different mutations in cancers." This was said by the former director of the US National Cancer Institute (NCI), Nobel Prize winner Dr. Harold Varmus.

Experts say there has been tremendous progress in cancer over the past five years, but a "cure" for all of its types is unlikely, with at least 200 of them. So finding one cure for cancer to deal with all of them is apparently impossible.

Therefore, oncologists do not believe in any prophecies about a cure for cancer ... Someday, as Vanga said, cancer should be "shackled with iron chains", but no one knows who this "blacksmith" will be.

A cure for cancer has long been the golden dream of many researchers. Many drugs and treatment regimens have been created, but so far there is no panacea for this formidable disease. Science has been searching for a cure for cancer for over a hundred years. A lot of research is being done in this direction. For the last thirty years, scientists have returned to the methods of immunotherapy. In 2013, cancer vaccines were listed as one of the top ten breakthroughs in science.

The search for a cancer vaccine

The main problem of effective treatment is that in oncological diseases, the immune system fails. In addition, cancer cells actively defend themselves by “exposing” special proteins to the surface. Therefore, the immune system simply "does not see" the tumor.

The cancer vaccine is not new. The American oncologist surgeon William Bradley Coley, who was given the title of "father of cancer immunotherapy", created his first vaccine back in 1893. It consisted of live, and later killed bacteria-causative agents of scarlet fever (streptococci). The vaccine has been successfully used to treat sarcoma and a number of other forms of cancer.

Many practicing physicians of the late 19th and early 20th centuries noted cases of spontaneous recovery of cancer patients when infected with a bacterial infection. This result is associated with a “shake-up” of the immune system. Unfortunately, William Coley's research did not have a sufficient scientific basis. With the development of radio and chemotherapy, his achievements were forgotten.

Here are some facts about the impact of infections on cancer.

  1. The BCG vaccine was tried to be used for cancer, but after 1935 it was discontinued due to low efficiency. However, during the studies, a positive relationship was found - early BCG vaccination prevented leukemia.
  2. University of California studies have shown that the Haemophilus influenzae (type B) vaccine reduces the risk of developing lymphoblastic leukemia in children.
  3. The hepatitis B vaccine is well known to prevent certain types of liver cancer.

The direction of immunotherapy received a new round with the development of science. The understanding came that the immune system is a subtle self-regulating mechanism with great potential.

What are the current cancer vaccines?

Actually, there is only one vaccine against oncological diseases in the classical sense. These are vaccinations "Gardasil" and "Cervarix" - from cervical cancer. The disease is caused by the human papillomavirus (HPV). When Professor Harald zur Hausen proved that HPV is the main cause of cervical cancer in women, it became possible to prevent this type of cancer. The vaccine is given before the onset of sexual activity at the age of 9 to 25–26 years.

All other cancer vaccines are not preventive, but curative. They do not contain a virus, but substances that stimulate anti-cancer immunity. That is, they are medicine.

Today, a large number of such immunopreparations are at the stage of clinical trials. But by the beginning of 2018, only a few of them were approved for widespread use. Vaccines only work for certain types of cancer.

  1. Japanese scientists have recreated William Coley's vaccine based on Streptococcus pyogenes. Thanks to their developments, there is a prostate cancer vaccine - Pitsibanil. In addition, in 2005, the Canadian pharmaceutical company MBVax Bioscience began producing the William Coley vaccine. Now the drug is at the stage of clinical trials.
  2. In 2010, the US FDA approved a vaccine based on dendritic cells - Provenge. It is used for immunotherapy in patients with prostate cancer. But it only prolongs life by a few months.
  3. For more than 30 years, there has been a vaccine based on the BCG strain. The drug is used in the treatment of bladder cancer.

These vaccinations are not 100% guaranteed. Therefore, development and research continues.

What are the areas of research

So far, most of the developments are aimed at creating therapeutic (therapeutic) vaccinations. They contain proteins, markers that stimulate the immune response. Enter them several times over the course of a year or more. The side effects of cancer vaccination are minor, compared to the damage from radiotherapy and chemotherapy. But doctors talk about cancer vaccines with caution. A good result is considered if the drug translates the disease into a chronic stage.

Currently, development is carried out in four directions.

  1. Vaccines containing whole cancer cells. The principle of action is the same as that of a conventional vaccination against infection. Cells are taken from the tumor, processed in the laboratory. If the cells are obtained from the patient's own tumor, then the vaccine is called autologous. A drug based on donor cancer cells is called allogeneic. Such a vaccine is made individually for each patient.
  2. Vaccines with antigens. The drug contains fragments of oncocells or individual proteins. This medicine works against a certain type of cancer.
  3. gene vaccines. Nucleotide sequences are inserted into a cancer cell and it begins to produce a protein (tumor antigen), to which the body's immunity reacts. Use the genes of pathogenic bacteria, yeast, viruses.
  4. Vaccines based on dendritic cells are a promising direction. To obtain such a drug, white blood cells are isolated from the patient's circulatory system, processed (turned into dendritic cells), “trained” with tumor antigens, and injected intravenously several times. After the vaccine is administered, the cells migrate to the lymph nodes and present tumor antigens to T cells there. Help the immune system "see" the enemy. To enhance the immune response, dendritic cells are combined with other substances, such as tetanus toxoid.

Cancer vaccines are being developed in many countries. The leading positions belong to the USA, Germany, Japan.

Latest news about cancer vaccines

Clinical trials of immunodrugs usually last for years. Here is news about the successful development of a cure for cancer over the past 5-8 years.

  1. A universal vaccine against all types of cancer is being developed at Stanford University. Experiments on rats showed a 97% recovery. Now researchers are recruiting people for the experiment, the treatment will last 12 months.
  2. The University of Pennsylvania has been developing a chronic lymphatic leukemia vaccine for 20 years. The achieved results - remission 1 year. Based on this vaccination, they plan to develop vaccines against lung cancer, ovarian cancer, myeloma and melanoma. Drugs are being tested for brain and pancreatic cancer.
  3. In 2010, good results were obtained in the treatment of pancreatic cancer at the Cancer University in New Jersey, USA.
  4. In 2011, American cancer researcher Larry Kwak and colleagues at the Andersen Center successfully applied their findings to patients with follicular lymphoma. Ipilimumab, a vaccine against melanoma, was also created there, which prolongs patients' lives up to 10 months.
  5. In 2014, at Thomas Jefferson University, under the direction of William Gillinders, twelve patients with a very aggressive type of cancer, glioblastoma, underwent clinical trials. The response to vaccination was 50%.
  6. Immunologist Mary Disis at the University of Washington applied the breast cancer vaccine in 2014. The drug was administered to women whose disease had progressed to the stage of metastasis. Most of the patients recovered completely.
  7. In 2014, prostate cancer vaccines Prostvac-V and Prostvac-F were successfully tested. They are made on the basis of cowpox and chickenpox virus. The drug is used in patients with advanced prostate cancer, not amenable to hormonal treatment.
  8. Swiss scientists in Lausanne have achieved good results in human trials using an acidic individual vaccine. It was administered to patients with ovarian cancer. Survival at 2 years was 80%.
    In Korea, good results have been reported on the use of vaccinations for pancreatic cancer in several hundred patients.

In total, about 300 vaccines against cancer are under development in the world.

A cancer vaccine has also been found in Cuba. Cuban scientists have developed the drug CimaVax-EGF. The vaccine has been tested against lung cancer, but doctors plan to use it against all types of cancer. Since 2009, large-scale clinical trials have been underway. Treatment of cancer patients at the Roswell Park Research Institute in Buffalo began in January 2018. Vaccination prolongs life by months, rarely by years. About 20% of patients do not respond to the administration of the drug. However, the Cuban vaccine was recognized in many countries. Despite the US ban on Cuban drugs, the drug is undergoing clinical trials in New York State. Japan and some European countries also brought the vaccine.

Cancer vaccines are being tested in many countries around the world. Today it is a very promising area of ​​medical science. Grants are allocated, special funds are created. However, none of the developed drugs gave a 100% result, they only prolong life compared to control groups.

Cancer vaccine in Russia

When will there be a cancer vaccine in Russia? The head of the Ministry of Health of the Russian Federation, Veronika Skvortsova, during a working meeting with President Vladimir Putin in July 2018, announced that a cancer vaccine had already been created as part of the national cancer control program. The drug works in this way - T-lymphocytes are taken from a sick person, modified and launched back. Due to shock therapy for immunity, recovery occurs. This is a personalized cancer vaccine, which has no analogues anywhere in the world. It is used for various types of cancer. So, the drug was tested on a patient with glioblastoma. The patient was in critical condition (coma and cerebral edema). The treatment was carried out in 2017–2018, which resulted in a reduction in the tumor, and the patient returned to work.

Leading institutes are engaged in the development of cancer vaccines in Russia. True, all drugs are at the stage of clinical trials.

At the oncological center of the Russian Academy of Medical Sciences. Blokhin successfully used genetically engineered and dendritic vaccines. Patients who should have died within a year are living. They are periodically dosed with the drug, as the experiment is still ongoing.

At the National Medical Research Center of Oncology named after N. N. Petrov in St. Petersburg, work on the creation of a personalized cancer vaccine has been underway since 1998. In 2003, the first patent for immunotherapy with dendritic cells was received, in 2008 - for the vaccine. Since 2010, permission has been given for clinical trials. Scientists use the autologous vaccine in severe cases (melanoma, colon or kidney cancer). It takes 10 days to create an individual vaccination. In the first two months, the patient receives four injections of the drug.

And also Russian scientists are working on the creation of a preventive vaccination against cancer. It is planned to be administered to patients with risk factors.

Let's draw conclusions. The question of whether there is a vaccine against cancer can be answered in the affirmative. Several drugs have been approved and are widely used. But they are not universal - they only protect against a certain type of cancer. Other vaccines are in clinical trials. These drugs work a little differently than regular vaccinations. Cancer vaccination boosts the immune system. It is different for everyone, so the existing preparations of some ballrooms heal in a miraculous way, others do not help. Scientists painstakingly study the mechanisms of action, make corrections, conduct new tests. All this takes a lot of time, so that cancer vaccination will not enter the daily medical practice for a long time, but the results achieved so far are already encouraging.

"There are no incurable diseases - there is a lack of knowledge"

V.I.Vernadsky


According to statistics, the main causes of death in the last century have been cardiovascular and oncological diseases. Millions of people lose their lives every year solely because of them. The main causes of CVD arehypodynamia, irrational nutrition, mental overstrain, bad habits, overweight. And if you generalize - then the way of life that has developed for the majority.


The cause of cancerous (oncological) diseases is not specified by official medicine.Among the alleged reasons areexcessive consumption of all kinds of artificial substances that allegedly improve the quality of food, which are added to many products during their production,and the widespread and frequent use of devices that create electromagnetic radiation, which has a very adverse effect on human health (these are mobile phones, and PCs, and microwaves, etc.). However, herethe question arises - but after all, the majority uses all these "benefits of mankind", and not everyone gets cancer, although, unfortunately,very many. get sickeven small children, whose exposurethe above reasons for a very short time. The number of cases of the disease is steadily increasing, and some scientists even believe that the end of the 20th century can be called the beginning of the cancer epidemic.After all, even cases have been recorded when entire familiesstricken with cancer!


In this regard, it is worth rememberingthat at the end of the 19th centuryRussian professor M.M. Rudnev, who studiestumors, the idea came that cancer is a contagious disease. But supporters oncogenetic theory, on the basis of which modern methods of treating oncological diseases have been created, are categorically deniedthis assumption, despite the fact that the mortality rate with the traditional approach to treatment is quite high.


Idea the creation of a vaccine came to him due to the fact thatSeveral cases have been reported in the past.complete recovery from cancer if the patient fell ill with erysipelas, the causative agent of which is the streptococcus bacterium. A similar case was recorded in his diaries by A.P. Chekhov.




About this was once an entry in the Great Medical Encyclopedia, later removed from there.

The effectiveness of the created vaccine was almost 100%.Inspired by this, Colliewrote many articles on the causes and treatment of cancer, on the manufacture of the vaccine and its dosage.

Thanks to his work, about 30 thousand lives were saved in many countries. It helped a lot thatthe cost of the vaccine was affordable to most, besides sick he did not have to go anywhere for treatment: having received the vaccine by mail, he could go to his doctor and be treated until he recovered.




The theory put forward by M.M. Nevyadomsky was fully confirmedexperimentally using electron microscopes, moreover, in laboratories in different countries. Elementary bodies were found in almost all the studied tumors! The only unanswered question is whycancer cells are very similar to the cells of the tissue in which they develop.


Mikhail Mikhailovich did not have time to answer him. Histhe laboratory was closed, and he himself was attacked in the entrance of his own house, as a result of which he hadBoth legs are seriously injured. And later he, one might say, "sank into oblivion." Surprisingly, we did not manage to find a single photograph of M.M. Nevyadomsky, although he was a prominent scientist and academician!


























Already in Soviet times, this theory became seriously interestedValery Alexandrovich Chereshnev , currently an academician of the Russian Academy of Medical Sciences. Almost forty years agoat the medical basemilitary-industrial complex of the Soviet Union made his discovery Previously, hemolytic streptococci of group A were constantly present in the human body, which, in the course of their vital activity, produced the enzymes necessary for its proper functioning. Some of them have a detrimental effect on tumor cells!


Based on this,Chereshnev managed to create an anti-cancer vaccine - Pirotat , whichcan also be used to treat cardiovascular diseases, leading among the causes of human death! At the same time, it was possible to scientifically justify the mechanism by which this vaccine works. It's all about enzymes. Some of them, without penetrating into healthy cells, havedirect detrimental effect on cancer cells, cause their degradation.Others eliminateobstruction of blood vessels, for example, by dissolving cholesterol plaques on the walls of blood vessels, thereby improving blood flow and providing unhindered access of oxygen to healthy cells and deliveringimmune cells to the sites of tumor formation. Still others are able to dissolve nucleic acids in elementary bodies, thereby preventing the spread of metastases, while destroying various viruses. Enzymes are also very importantlead cancer cells to starvation, dissolving glucose in the places of their accumulation, which leads to a noticeable inhibition of tumor growth. These same enzymes play an important role in the treatment of diabetes.





From the foregoing, it can be seen what an indispensable assistantis to maintain human health streptococcus, which disappeared from the body due to the widespread use of antibiotics in the post-war period.It is difficult, and not necessary, to argue with the fact that antibiotics have made a huge contribution to the treatment of many diseases. But preciselyafter their discovery, the number ofcancer, cardiovascular and viraldiseases, and cases of diabetes.


Introduction to the body of streptococci after a course of antibiotic treatment Maybe significantly reduce the likelihood of developing theseterrible diseases. Moreover, at the moment, Academician V.A. Chereshnev has patented a method for introducing streptococci into the body by simply rubbing into the skin. Use vaccine developed V.A. Chereshnev, it is possible not only to treat cancer and CVD, but also to conduct them prevention, at the same time and healing the body as a whole.


It is sad to talk about it, but we have to state the fact that millions of people could have survived, andthose who have recovered from cancerhad a chance not to undergo painful procedures during treatment, becamevictims not so much of a terrible disease as victims of the terrible deeds of people who by all means prevented (and continue to do so now) the wide distribution and use for treatment effective oncology and very affordable drugs. Here we have not talked about all the revolutionary developments in this area. There were many, but allthey were rejected by official medicine, and their developers, for the most part, were subjected tocruel persecution. Questions about who benefits from this have already set their teeth on edge, because the answer to them is the same - for those for whom money and power are most important.


But there is another more important question, which a person, struck bya terrible disease- the question of whyAnd why was this disease given to him? What exactly led him to such a diagnosis?What is the true meaning and cause of the disease? Note that the question is not “why?” but"For what?".





If, by the will of fate, you or your loved ones have been overtaken by such a misfortune, we strongly advise you to turn to the books of Anastasia Novykh! From them you will learn the thoughts and experiences of a young girl who personally went through all the horrors and bouts of despair after she accidentally heard her diagnosis. Learn how to emerge victorious from a duel with death and continue not to get into such situations. Find out how you can not only recover, but alsosignificantly raise the level and quality your life after the illness! It is for you that we have placed on our website absolutely freebooks by Anastasia Novykh! Download, read, get inspired, act and BE HEALTHY!

Read more about this in the books of Anastasia Novykh

(click on the quote to download the entire book for free):

At the beginning of the school year of the last graduation class, I began to notice constant headaches, and strong and prolonged. My parents took me for an examination. The results, for the most part, the doctors discussed with them in private. This made me very worried. And vague doubts one after another began to torment my soul. After all, complete uncertainty was the worst.

And all these circumstances were terribly frightening until a certain moment, when I accidentally overheard the mother’s conversation with the professor:

- ...but there must be some way out?

Of course, you can always find a way out. You see, this little tumor can become progressive over time. And this is very dangerous. It is advisable to have the operation now, before it is too late… In Moscow, by the way, there is a very good clinic for these problems with excellent specialists. Yes, but it's hard to get there. Recording years ahead. And the girl needs, you know, as quickly as possible. Otherwise ... it is difficult to predict the development of the disease, especially if the tumor is in the brain. Sometimes a person lives a year, and sometimes longer .... But, in any case, you should not despair. Maybe you will be able to break through an acquaintance or connections ...

The next words flew by. Only one phrase pounded in my head: “A year ... And that’s it!” Doom and emptiness hovered around. The noisy hospital bustle began to gradually move away, giving way to a growing flurry of thoughts: “To die in the prime of life! But I haven't even lived yet... Why me? What have I done so badly in my life?!” It was a cry of despair. Tears rolled down his cheeks like a hail. It became unbearably stuffy in this hospital crypt, and I ran to the exit. And in my ears, like a menacing echo, the voice of the professor sounded: “One year! One year… One!”

The fresh air hit me in the face with its intoxicating aroma. Gradually I came to my senses and looked around. After the rain, the trees stood like in a fairy tale, with sparkling diamond pendants. All around shone purity and novelty. The heat emanating from the ground covered the asphalt with a light haze, giving the impression of the unreality of what was happening. God, how good it was around! That beauty of nature, which I had not noticed before, now acquired for me some new meaning, some new charm of its own. All the petty problems, because of which she was so worried every day, now seemed so stupid and worthless. With bitterness and longing, looking at the bright sun, fresh greenery, the cheerful call of birds, I thought: “What a stupid waste of my life. What a pity that I didn’t have time to do anything really worthwhile in it! All previous grievances, gossip, fuss - everything has lost its meaning. Now the people around me were lucky, and I was a prisoner of the castle of Death.

- Anastasia NOVICH Sensei I

In the first months of 2019, several countries at once announced the invention of a drug capable of defeating cancer. According to statistics, cancer is the second leading cause of death after cardiovascular disease. Every sixth person dies from this deadly disease every day. Oncologists all over the world are constantly working on a drug that will help stop an incurable disease and give a chance to those who are already sick.

Latest news 2019 about the cure for cancer

Only a month and a half of the new year 2019 has passed, and several countries have already made loud statements about the invention of a cure for cancer.

The Israeli company Accelerated Evolution Biotechnologies was the first to announce the victory of cancer. Moreover, scientists claim that their medicine has no side effects. The action of a new drug called Multipurpose Toxin is aimed at destroying a cancer cell with microscopic peptides that envelop it from all sides. Scientists say that the drug will be effective from the first day of administration, the cost will be low, and there will be no side effects at all. Unlike other cancer drugs, which act only on a specific point and kill fast-growing cells, the new drug destroys even slow-growing cancer stem cells. But it is they who, after undergoing treatment, completely return the disease and lead to death.

A little later, the British Institute for Cancer Research made a loud statement. The new drug, which has already passed all clinical trials, is effective in treating six types of a deadly disease. Tumors after taking it either became smaller or stopped growing. What is the main active ingredient is kept secret, and the medicine is administered intravenously. The drug was tested even on terminally ill patients. The most effective medicine has shown itself in the fight against cancer of the female genital organs, lungs, bladder and esophagus. Scientists claim that the drug will be available to ordinary patients in five years.

The next statement was the message of US biologists that the HIV drug kills aggressive cancer cells. However, this only applies to breast cancer. However, scientists plan to continue to study the effect of the drug on other forms of oncology. It has already been found that it also inhibits the development of cells that cause skin, pancreatic, and lung cancer.

How is cancer treatment going now?

Despite the almost weekly high-profile statements about miraculous drugs that are ready to cope with a deadly disease in one injection or after the first pill, active oncologists say that the disease has not yet been defeated. And the most effective in the fight against it remain surgical removal of the tumor, chemical and laser therapies.

Statistics claim that only 20 people in the world managed to get rid of the deadly disease completely, without subsequent remission. Scientists explain such inefficiency in the invention of a drug for cancer by the fact that the drug takes decades from the laboratory to the patient. The process has many stages, and if at one of them the studies show that it is ineffective or harmful, the study stops.

Not uncommon during clinical trials of drugs against cancer is the death of the test subjects. Those. even if the tests on animals were positive, this does not prove that the same effect will be after applying it to a person.

Siberian scientists generally argue that no artificially invented drug for cancer is needed, and it is necessary to work only with human immunity. He himself must recognize the enemy in the form of cancer cells, attack them and win.

CATEGORIES

POPULAR ARTICLES

2023 "kingad.ru" - ultrasound examination of human organs